Effect of 17-α hydroxyprogesterone caproate on the production of tumor necrosis factor-α and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants

Journal of Perinatology

Volumn 30, Issue 9, 2010, Pages 584-589

  Patel, S ^a   Li, A ^a   Goodwin, T M ^a   Brower, M ^b   Blitz, M ^a   Minoo, P ^a   Felix, J C ^a   Lee, R H ^a  

^a LAC USC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; HYDROXYPROGESTERONE CAPROATE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MYOMETRIUM; NONPARAMETRIC TEST; PREGNANCY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE;

CELLS, CULTURED; CYCLOOXYGENASE 2; FEMALE; HUMANS; HYDROXYPROGESTERONES; LIPOPOLYSACCHARIDES; MYOMETRIUM; PREGNANCY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956268397     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.23     Document Type: Article

References (38)

1. Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increase risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-424.
2. Slater DM, Dennes WJ, Campa JS, Poston L, Bennett PR. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod 1999; 5(9): 880-884.
3. Sooranna SR, Lee Y, Kim LU, Mohan AR, Bennett PR, Johnson MR. Mechanical stretch activates type 2 cyclooxygenase via activator protein-1 transcription factor in human myometrial cells. Mol Hum Reprod 2004; 10(2): 109-113.
4. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292(4): 462-469.
5. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342(20): 1500-1507.
6. Houben M, Nikkels P, van Bleek G, Visser G, Rovers M, Kessel H et al. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a crosssectional study. PLoS ONE 2009; 4(8): e6572.
7. Peltier M, Tee S, Smulian J. Effect of progesterone on proinflammatory cytokine production by monocytes stimulated with pathogens associated with preterm birth. Am J Reprod Immunol 2008; 60(4): 346-353.
8. Watari M, Watari H, DiSanto M, Chacko S, Shi G, Strauss J. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol 1999; 154(6): 1755-1762.
9. Inglis S, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak F et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994; 171(1): 5-10.
10. Sadowsky D, Adams K, Gravett M, Witkin S, Novy M. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195: 1578-1589.
11. Pu J, Zeng WY. Relationship among TNF-alpha gene promoter -308 site polymorphism, the levels of maternal serum TNF-alpha, and the mRNA expression placental TNF-alpha in preterm labor. Sichuan Da Xue Xue Bao Yi Xue Ban 2009; 40(1): 77-80.
12. Erkinheimo TL, Saukkonen K, Narko K, Jalkanen J, Ylikorkala O, Ristimaki A. Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium. J Clin Endocrinol Metab 2000; 85: 3468-3475.
13. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348(24): 2379-2385.
14. Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A. 17a-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Am J Perinatol 2008; 25: 503-506.
15. Tyson-Capper AJ, Europe-Finner GN. Novel targeting of cyclooxygenase-2 (COX-2) premRNA using antisense morpholino oligonucleotides directed to the 30 acceptor and 50 donor splice sites of exon 4: suppression of COX-2 activity in human amnion-derived WISH and myometrial cells. Mol Pharm 2006; 69(3): 796-804.
16. Sexton D, OReilly M, Friel A, Morrison J. Functional effects of 17alphahydroxyprogesterone caproate (17P) on human myometrial contractility in vitro. Reprod Biol Endocrinol 2004; 2(1): 80.
17. Hardy DB, Janowski BA, Corey DR, Mendelson CR. Progesterone receptor plays a major antiinflammatory role in human myomterial cells by antagonism of nuclear factor-kB activation of cyclooxygenase 2 expression. Mol Endocrinol 2006; 20: 2724-2733.
18. Hatthachote P, Gillespie JI. Complex interactions between sex steroids and cytokines in the human pregnant myometrium: evidence for an autocrine signaling system at term. Endocrinology 1999; 140(6): 2533-2540.
19. Li A, Lee RH, Felix JC, Minoo P, Goodwin TM. Alteration of secretory leukocyte protease inhibitor in human myometrium during labor. Am J Obstet Gynecol 2009; 200(3): 311. e1-311. e10.
20. Jain JK, Li A, Minoo P, Nucatola DL, Felix JC. The effect of nonoxynol-9 on human endometrium. Contraception 2005; 71: 137-142.
21. Li A, Felix JC, Hao J, Minoo P, Jain JK. Menstrual-like breakdown and apoptosis in human endometrial explants. Hum Reprod 2005; 20: 1709-1719.
22. Li A, Felix JC, Minoo P, Amezcua CA, Jain JK. Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. Fertil Steril 2005; 84: 202-211.
23. Jain JK, Li A, Nucatola DL, Minoo P, Felix JC. Nonoxynol-9 induces apoptosis of endometrial explants by both caspase-dependent and -independent apoptotic pathways. Biol Reprod 2005; 73: 382-388.
24. Nap AW, Dunselman GA, de Goeij AF, Evers JL, Groothuis PG. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum Reprod 2004; 19(10): 2180-2187.
25. Ruddock NK, Shi S-Q, Jain S, Moore G, Hankins G, Romero R et al. Progesterone, but not 17-alpha hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 2008; 199: 391.e1-391.e7.
26. Keiser S, Veillon E, Parrish M, Bennett W, Cockrell K, Fournier L et al. Effects of 17-hydroxyprogesterone on tumor necrosis factor-a-induced hypertension during pregnancy. Am J Hypertens 2009; 22(10): 1120-1125.
27. Veillon E, Keiser S, Parrish M, Bennett W, Cockrell K, Ray L et al. 17-hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol 2009; 201(3): 324. e1-323. e6.
28. Amory J, Lawler R, Shields L. Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women. J Perinat Med 2005; 33(6): 506-509.
29. Johnson JWC, Lee PA, Zachary AS, Calhoun S, Migeon CJ. High-risk prematurityprogestin treatment and steroid studies. Obstet Gynecol 1979; 54(4): 412-418.
30. Hartikainen-Sorri A, Kauppila A, Tuimala R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56(6): 692-695.
31. Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR, Caritis SN. Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol 2007; 197(6): 599.e1-599.e7.
32. Benjamin D, Jost JP. Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. Nucleic Acids Res 2001; 29(17): 3603-3610.
33. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001; 15(Suppl 2): 78-89.
34. Jansen PW, Tiemeier H, Jaddoe VWV, Hofman A, Steegers EAP, Verhulst FC et al. Explaining educational inequalities in preterm birth: the generation r study. Arch Dis Child Fetal Neontal Ed 2009; 94(1): F28-F34.
35. Moutquin JM. Socio-economic and psychosocial factors in the management and prevention of preterm labour. BJOG 2003; 110(Suppl 20): 56-60.
36. Goffinet F. Primary predictors of preterm labour. BJOG 2005; 112(Suppl 1): 38-47.
37. ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 2000; 15: 1856-1864.
38. ACOG Committee opinion no. 419. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008; 112: 963-965.